International Lung Cancer Summit

Join us for the 6th International Lung Cancer Summit (#ILCS24), live in Lausanne or online, with our hosts Peters Solange (CHUV | Lausanne university hospital) and Alfredo Addeo (HUG - Hopitaux Universitaires de Genève), alongside leading world experts and industry representatives, to discuss the latest advances in thoracic oncology. Connect with keynote speakers 🧑⚕️👩⚕️ Anne Schultheis, Anne-Marie Dingemans, Roberto Ferraro, Biagio Ricciuti, Jarushka Naidoo, Nuria Maria Novoa, Delvys Rodriguez-Abreu, MD, PhD, Giannis Mountzios, Sandip Patel, M.D., and Stephen Liu. Our supporters 🤝 International Association for the Study of Lung Cancer, ETOP IBCSG Partners Foundation, Fondation ISREC 🗓️ Friday, 4th October 2024 from 10AM CET 📍 CHUV | Lausanne university hospital Secure your seat now ➡️ https://lnkd.in/dH3P4jCj

🚨 The #ILCS24 is just ONE MONTH away! We're excited to explore the latest discoveries and therapeutic advances in thoracic oncology, alongside Peters Solange and Alfredo Addeo as your hosts! Connect with global experts, live in Lausanne or virtually online: Anne Schultheis, Anne-Marie Dingemans, Roberto Ferrara, Biagio Ricciuti, Jarushka Naidoo, Nuria Maria Novoa, Delvys Rodriguez-Abreu, MD, PhD, Giannis Mountzios, Sandip Patel, M.D., and Stephen Liu. 🗓️ Friday, 4th October 2024 from 10AM CET Have you secured your seat? Register before it's too late: https://lnkd.in/gMwe2BFP

Should we take every opportunity to cease immunotherapy for advanced #NSCLC to balance efficacy, toxicity and patient-centered care? Join Giannis Mountzios to explore this question at the #ILCS24, and share your insights! ⏰ Friday, 4th October from 10AM CET Register your seat now ➡️ https://lnkd.in/gMwe2BFP

(English below) 🚀 Après l’immense succès de l'édition 2023, qui a attiré plus de 1600 participants en ligne et sur place, le CHUV / Centre hospitalier universitaire vaudois est fier d'accueillir à nouveau l' International Lung Cancer Summit (ILCS). 🎯 Le programme de cette année couvrira un large éventail de sujets, notamment le cancer du poumon non à petites cellules à un stade précoce, les avancées dans le domaine du cancer du poumon à petites cellules, les inhibiteurs du point de contrôle immunitaire et les tests tumoraux. Réservez vos places ! ⤵ --- 🚀 After the immense success of the 2023 edition, which attracted more than 1,600 participants both online and in person, the Lausanne University Hospital (CHUV) is proud to once again host the International Lung Cancer Summit (ILCS).   🎯 This year's program will cover a wide range of topics, including early-stage non-small cell lung cancer, advancements in small cell lung cancer, immune checkpoint inhibitors, and tumor testing. Reserve your spot! ⤵

Just out! 5 year FU of CheckMate 9LA. Great to see, that there is consistent efficacy for some difficult patient groups. Thank you for a great cooperation! nNGM Lungenkrebs | Nationales Netzwerk Genomische Medizin Deutsches Zentrum für Lungenforschung (DZL) Marketing LungenClinic LungenClinic Grosshansdorf GmbH Elsevier Oncology

What is the current therapeutic landscape for #LungCancer with KRAS, HER2, and C-MET alterations? 🫁 Explore the topic with Biagio Ricciuti at the upcoming #ILCS24, live in Lausanne or virtually online! 🗓️ 4th October 2024, from 10AM CET Register your seat and get involved in the discussion ➡️ https://lnkd.in/gMwe2BFP

The FDA has recently approved two new treatments for #NSCLC, including: 💊 Durvalumab in combination with platinum-containing chemotherapy as a neoadjuvant treatment, followed by single-agent durvalumab as adjuvant therapy for resectable NSCLC. 💊 Lazertinib in combination with amivantamab-vmjw for the first-line treatment of locally advanced or metastatic NSCLC with specific #EGFR mutations. Read more about the approvals ➡️ https://lnkd.in/eDtbMZeb

The #ILCS24 is a space for leading medical professionals from around the world will convene and discuss the latest advancements in #LungCancer research and treatment 🫁 Last year’s summit was highly praised by attendees for its in-depth sessions and valuable networking opportunities. This year, we aim to further elevate the conversation and collaboration in the fight against lung cancer. Don't miss this opportunity to advance your expertise and contribute to the future of lung cancer care ➡️ https://lnkd.in/dH3P4jCj

How much tissue do we need for pathological testing for early #LungCancer? 🫁 Hear insights from Lukas Bubendorf, plus much more on tissue acquisition, thoracic surgery, and targeted therapies with Isabelle Schmitt-Opitz, Carolin Steinack, Brendon Stiles and Martin Reck ➡ https://lnkd.in/eRaVt4Nj

Join Jarushka Naidoo, live in the beautiful city of Lausanne or virtually online, to explore the role of #ADCs in lung cancer treatment at the upcoming #ILCS24! 🗓️ 4th October, 2024 from 10AM CET Secure your seat and get involved in the discussion with leading experts ➡️ https://lnkd.in/gMwe2BFP